Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 5.52
(-0.18%)
CNY 5.52
(-0.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 86.96 Million CNY | -16.96% |
| 2022 | 36.52 Million CNY | -32.13% |
| 2021 | 119.89 Million CNY | 27.51% |
| 2020 | 44.83 Million CNY | 10.34% |
| 2019 | 79.58 Million CNY | -30.53% |
| 2018 | 119.4 Million CNY | -17.1% |
| 2017 | 168.85 Million CNY | 3.08% |
| 2016 | 148.92 Million CNY | -38.66% |
| 2015 | 275.17 Million CNY | 16.96% |
| 2014 | 216.58 Million CNY | 61.89% |
| 2013 | 147.72 Million CNY | 17.0% |
| 2012 | 126.06 Million CNY | 32.12% |
| 2011 | 93.96 Million CNY | 38.3% |
| 2010 | 69.09 Million CNY | 29.56% |
| 2009 | 53.38 Million CNY | 39.47% |
| 2008 | 38.5 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 16.76 Million CNY | 25.33% |
| 2024 Q3 | 1.92 Million CNY | -91.46% |
| 2024 Q1 | -1.08 Million CNY | 10.13% |
| 2023 Q1 | 13.37 Million CNY | 142.23% |
| 2023 Q4 | 16.35 Million CNY | 23.54% |
| 2023 FY | - CNY | -16.96% |
| 2023 Q3 | 13.24 Million CNY | 2.76% |
| 2023 Q2 | 12.88 Million CNY | -3.68% |
| 2022 FY | - CNY | -32.13% |
| 2022 Q3 | 18.24 Million CNY | -27.08% |
| 2022 Q4 | -31.68 Million CNY | -273.64% |
| 2022 Q1 | 24.3 Million CNY | 21.86% |
| 2022 Q2 | 25.02 Million CNY | 2.97% |
| 2021 Q4 | 19.94 Million CNY | -40.7% |
| 2021 Q1 | 14.98 Million CNY | -37.23% |
| 2021 Q2 | 18.07 Million CNY | 20.62% |
| 2021 Q3 | 33.63 Million CNY | 86.13% |
| 2021 FY | - CNY | 27.51% |
| 2020 FY | - CNY | 10.34% |
| 2020 Q4 | 23.86 Million CNY | -30.05% |
| 2020 Q3 | 34.11 Million CNY | 71.38% |
| 2020 Q2 | 19.9 Million CNY | 225.26% |
| 2020 Q1 | -15.89 Million CNY | -209.98% |
| 2019 FY | - CNY | -30.53% |
| 2019 Q4 | 14.44 Million CNY | 121.49% |
| 2019 Q3 | 6.52 Million CNY | -74.01% |
| 2019 Q2 | 25.1 Million CNY | 88.63% |
| 2019 Q1 | 13.3 Million CNY | 1359.05% |
| 2018 Q2 | 37.42 Million CNY | 19.02% |
| 2018 Q1 | 31.44 Million CNY | -34.14% |
| 2018 Q3 | 40.43 Million CNY | 8.06% |
| 2018 FY | - CNY | -17.1% |
| 2018 Q4 | 911.99 Thousand CNY | -97.74% |
| 2017 Q2 | 40.92 Million CNY | 113.08% |
| 2017 Q4 | 47.73 Million CNY | 43.32% |
| 2017 FY | - CNY | 3.08% |
| 2017 Q1 | 19.2 Million CNY | -13.07% |
| 2017 Q3 | 33.3 Million CNY | -18.61% |
| 2016 Q2 | 32.93 Million CNY | -2.98% |
| 2016 Q3 | 35.34 Million CNY | 7.32% |
| 2016 Q4 | 22.09 Million CNY | -37.5% |
| 2016 FY | - CNY | -38.66% |
| 2016 Q1 | 33.94 Million CNY | -62.07% |
| 2015 Q2 | 63.8 Million CNY | 136.75% |
| 2015 Q4 | 89.49 Million CNY | 55.95% |
| 2015 FY | - CNY | 16.96% |
| 2015 Q3 | 57.39 Million CNY | -10.05% |
| 2015 Q1 | 26.94 Million CNY | -72.01% |
| 2014 FY | - CNY | 61.89% |
| 2014 Q4 | 96.26 Million CNY | 162.54% |
| 2014 Q3 | 36.66 Million CNY | -23.07% |
| 2014 Q2 | 47.66 Million CNY | 134.49% |
| 2014 Q1 | 20.32 Million CNY | -22.58% |
| 2013 Q3 | 38.93 Million CNY | -19.11% |
| 2013 FY | - CNY | 17.0% |
| 2013 Q2 | 48.13 Million CNY | 69.89% |
| 2013 Q4 | 26.25 Million CNY | -32.57% |
| 2013 Q1 | 28.33 Million CNY | -14.9% |
| 2012 Q1 | 20.31 Million CNY | -8.47% |
| 2012 Q2 | 34.23 Million CNY | 68.47% |
| 2012 FY | - CNY | 32.12% |
| 2012 Q3 | 31.57 Million CNY | -7.75% |
| 2012 Q4 | 33.29 Million CNY | 5.44% |
| 2011 Q1 | 17.68 Million CNY | 0.0% |
| 2011 Q3 | 23.81 Million CNY | -3.64% |
| 2011 Q2 | 24.71 Million CNY | 39.73% |
| 2011 FY | - CNY | 38.3% |
| 2011 Q4 | 22.2 Million CNY | -6.77% |
| 2010 FY | - CNY | 29.56% |
| 2009 FY | - CNY | 39.47% |
| 2008 FY | - CNY | 0.0% |